Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rinn Song

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
The Pediatric Infectious Disease Journal|February 28, 2023
Rapid and Accurate Diagnosis of Pediatric Tuberculosis Disease: A Diagnostic Accuracy Study for Pediatric TuberculosisLaura Olbrich, Marriott Nliwasa, Issa Sabi, et al.
The Lancet Regional Health. Europe|April 28, 2025
Clinical presentation, diagnostics, and outcomes of infants with congenital and postnatal tuberculosis: a multicentre cohort study of the Paediatric Tuberculosis Network European Trials Group (ptbnet)Florian Götzinger, Alejandra Alonso Caprile, Antoni Noguera-Julian, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
PERFORMANCE OF FUJILAM VERSION 1 FOR THE DIAGNOSIS OF TUBERCULOSIS IN CHILDREN UNDER 5 YEARS IN UGANDA - A BRIEF REPORTMirembe Angella Nanteza, Nelson Mukiza, Freddie Bwanga, et al.
The Lancet. Infectious Diseases|November 2, 2023
Diagnostic accuracy of a three-gene Mycobacterium tuberculosis host response cartridge using fingerstick blood for childhood tuberculosis: a multicentre prospective study in low-income and middle-income countriesLaura Olbrich, Valsan P Verghese, Zoe Franckling-Smith, et al.
The Lancet. Infectious Diseases|September 23, 2024
Sequential and parallel testing for microbiological confirmation of tuberculosis disease in children in five low-income and middle-income countries: a secondary analysis of the RaPaed-TB studyLaura Olbrich, Zoe Franckling-Smith, Leyla Larsson, et al.
Lancet (London, England)|June 12, 2022
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trialGrace Li, Federica Cappuccini, Natalie G Marchevsky, et al.
Medrxiv : the Preprint Server for Health Sciences|March 17, 2025
Dietary plant diversity predicts early life microbiome maturationTeresa K McDonald, Ammara Aqeel, Ben Neubert, et al.
Open Forum Infectious Diseases|April 23, 2025
Oral Swab Testing With Xpert MTB/RIF Ultra for the Diagnosis of Tuberculosis in Children Aged <5 Years in Uganda: An Exploratory Interim Analysis of Diagnostic Accuracy in the NOD-pedFEND CohortNisreen Khambati, Kanyange Angel Moureen, Francesca Wanda Basile, et al.
Lancet (London, England)|September 4, 2021
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)Amy Flaxman, Natalie G Marchevsky, Daniel Jenkin, et al.
Clinical and Experimental Immunology|February 2, 2023
Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trialsMerryn Voysey, Amy Flaxman, Jeremy Aboagye, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
The Pediatric Infectious Disease Journal|February 28, 2023
Rapid and Accurate Diagnosis of Pediatric Tuberculosis Disease: A Diagnostic Accuracy Study for Pediatric TuberculosisLaura Olbrich, Marriott Nliwasa, Issa Sabi, et al.
The Lancet Regional Health. Europe|April 28, 2025
Clinical presentation, diagnostics, and outcomes of infants with congenital and postnatal tuberculosis: a multicentre cohort study of the Paediatric Tuberculosis Network European Trials Group (ptbnet)Florian Götzinger, Alejandra Alonso Caprile, Antoni Noguera-Julian, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
PERFORMANCE OF FUJILAM VERSION 1 FOR THE DIAGNOSIS OF TUBERCULOSIS IN CHILDREN UNDER 5 YEARS IN UGANDA - A BRIEF REPORTMirembe Angella Nanteza, Nelson Mukiza, Freddie Bwanga, et al.
The Lancet. Infectious Diseases|November 2, 2023
Diagnostic accuracy of a three-gene Mycobacterium tuberculosis host response cartridge using fingerstick blood for childhood tuberculosis: a multicentre prospective study in low-income and middle-income countriesLaura Olbrich, Valsan P Verghese, Zoe Franckling-Smith, et al.
The Lancet. Infectious Diseases|September 23, 2024
Sequential and parallel testing for microbiological confirmation of tuberculosis disease in children in five low-income and middle-income countries: a secondary analysis of the RaPaed-TB studyLaura Olbrich, Zoe Franckling-Smith, Leyla Larsson, et al.
Lancet (London, England)|June 12, 2022
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trialGrace Li, Federica Cappuccini, Natalie G Marchevsky, et al.
Medrxiv : the Preprint Server for Health Sciences|March 17, 2025
Dietary plant diversity predicts early life microbiome maturationTeresa K McDonald, Ammara Aqeel, Ben Neubert, et al.
Open Forum Infectious Diseases|April 23, 2025
Oral Swab Testing With Xpert MTB/RIF Ultra for the Diagnosis of Tuberculosis in Children Aged <5 Years in Uganda: An Exploratory Interim Analysis of Diagnostic Accuracy in the NOD-pedFEND CohortNisreen Khambati, Kanyange Angel Moureen, Francesca Wanda Basile, et al.
Lancet (London, England)|September 4, 2021
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)Amy Flaxman, Natalie G Marchevsky, Daniel Jenkin, et al.
Clinical and Experimental Immunology|February 2, 2023
Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trialsMerryn Voysey, Amy Flaxman, Jeremy Aboagye, et al.
Pageof 5